NYSE$AMWL
American Well Corp · Q3 2021 earnings
Q3 2021 earnings · · Investor relations
Briefing
Announced results for the third quarter of 2021.
Amwell's total revenue was $62.2 million, with a gross margin of 43.5%. The company had a net loss of $50.9 million and an adjusted EBITDA of ($31.5) million. Total active providers were approximately 80,000 and total visits were approximately 1.4 million.
- Revenue of $62.2 million in the third quarter
- Gross margins of 43% of revenue compared to 33% last year
- Total visits of 1.4 million
- Total active providers of approximately 80,000 at the end of the third quarter versus 71,000 last quarter and 62,000 last year
Headline financials
Revenue & EPS history
American Well · Revenue · Quarterly
$62.2M
Revenue by segment
American Well · $56.7M total across 2 segments · Q3 2021
- AMG Visit Revenue$30M+5.3%52.9%
- Subscription Revenue$26.7M+3.5%47.1%
Forward guidance
For 2021, the Company is narrowing and adjusting their previous visits outlook as a direct result of the impact of the COVID-Delta variant and now expects: Revenue between $246 and $253 million and Adjusted EBITDA between ($143) and ($136) million.
Tailwinds
- Acknowledges gross margin expansion due to visit mix shift more toward high margin urgent care
- Overall operational efficiencies
Headwinds
- Revenue between $246 and $253 million from the previous range of $252 to $262 million
- Mainly to account for decreases in visit volume
- Shifts in visit-type mix toward urgent care versus specialty due to the COVID-Delta variant
- AMG visit volume to end the year at the lower quartile of the range of 1.4 and 1.5 million
- Adjusted EBITDA between ($143) and ($136) million from the previous range of ($154) and ($146) million
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2021
+1.4%
Avg return
Earnings day
+2.1%
Avg return
5 days after
-2.2%
Avg return
30 days after
41%
9 / 22 earnings
Positive
+33.8%
Q2 2024
Best reaction
-20.9%
Q1 2021
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -2.0% | +27.2% | +34.0% | |
| Q4 2025 | +24.7% | +34.9% | +29.8% | |
| Q3 2025 | -9.5% | -20.0% | -20.6% | |
| Q1 2025 | +19.7% | +9.5% | +8.9% | |
| Q4 2024 | -5.0% | -3.6% | -35.5% | |
| Q3 2024 | -5.0% | -5.4% | -0.7% | |
| Q2 2024 | +33.8% | +13.9% | -1.1% | |
| Q1 2024 | +2.0% | +11.4% | -16.3% | |
| Q4 2023 | +23.6% | +20.8% | -16.0% | |
| Q3 2023 | +14.5% | +4.3% | +11.1% | |
| Q2 2023 | -8.3% | -13.9% | -35.2% | |
| Q1 2023 | -3.9% | -2.9% | +17.9% | |
| Q4 2022 | -13.1% | -19.2% | -37.3% | |
| Q3 2022 | -2.2% | +14.9% | -8.3% | |
| Q2 2022 | +9.2% | +6.8% | -4.8% | |
| Q1 2022 | -10.8% | +8.8% | +37.6% | |
| Q4 2021 | +7.2% | +1.0% | -8.0% | |
| Q3 2021 | -7.4% | -3.7% | -29.7% | |
| Q2 2021 | +0.7% | -1.7% | +0.8% | |
| Q1 2021 | -20.9% | -5.7% | +9.5% | |
| Q4 2020 | -4.1% | -10.8% | -1.5% | |
| Q3 2020 | -11.9% | -19.8% | +17.1% | |
| Q2 2020 | — | — | — | |
| Q1 2020 | — | — | — | |
| Q4 2019 | — | — | — | |
| Q3 2019 | — | — | — | |
| Q2 2019 | — | — | — | |
| Q1 2019 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro